SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123485
Filing Date
2024-11-07
Accepted
2024-11-07 16:58:11
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20240930.htm   iXBRL 10-Q 2683178
2 EX-10.2 vtyx-ex10_2.htm EX-10.2 122559
3 EX-10.3 vtyx-ex10_3.htm EX-10.3 26017
4 EX-10.4 vtyx-ex10_4.htm EX-10.4 36818
5 EX-10.5 vtyx-ex10_5.htm EX-10.5 117740
6 EX-31.1 vtyx-ex31_1.htm EX-31.1 17640
7 EX-31.2 vtyx-ex31_2.htm EX-31.2 17691
8 EX-32.1 vtyx-ex32_1.htm EX-32.1 10166
9 EX-32.2 vtyx-ex32_2.htm EX-32.2 10212
10 GRAPHIC img173884841_0.jpg GRAPHIC 4734
11 GRAPHIC img174808362_0.jpg GRAPHIC 4734
  Complete submission text file 0000950170-24-123485.txt   10112843

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vtyx-20240930.xsd EX-101.SCH 1189140
77 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20240930_htm.xml XML 1768125
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 241436850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)